Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED | N.MMED.WA | N.MMED.WR | N.MMED.WS

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

NDAQ:MNMD - Post Discussion

Mind Medicine (MindMed) Inc > Mindmed To Conduct 15-To-1 Reverse Split To Meet Nasdaq List
View:
Post by AwareInvestor on Aug 05, 2022 8:43am

Mindmed To Conduct 15-To-1 Reverse Split To Meet Nasdaq List

In a classic Canadian small cap move, Mind Medicine last night announced that it’s directors have approved a share consolidation. The consolidation follows an announcement in May that the company would be conducting an at-the-market financing to the tune of $100 million.
Comment by Bullknit101 on Aug 10, 2022 8:00am
Once the do the split, although they will mee the NASDAQ listing requirements, the stock will likely have room to tumble even more. The best strategy is to grab the train on the way out of the station. This one looks like it was pumped and dumped according to the chart. Psychedelics have a long way to go and the US feds have no appetite to legalize despite what you might say about some states. It& ...more